Submission of certificate under Reg. 74(5) of SEBI (DP) 30.06.2024
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kobo Biotech has submitted to BSE a certificate from its Registrar and Share Transfer Agent, XL Softech Systems Ltd, confirming compliance with SEBI's Regulation 74(5) for the quarter ended 30 June 2024. The certificate verifies that all share certificates received for dematerialization during the quarter were properly processed, confirmed to the depositories, and that the corresponding physical certificates were mutilated and cancelled within 30 days. Notably, the letter is signed by Namrata Randeri in her capacity as an Insolvency Professional (IBBI registered), with the correspondence email id being 'cirp.kobobiotech@gmail.com', indicating the company is currently under the Corporate Insolvency Resolution Process. The filing is a routine procedural compliance submitted to the stock exchange for record purposes.
This is a routine regulatory compliance filing and is unlikely to have any direct impact on the stock price. However, the continued involvement of an Insolvency Professional as the signatory reinforces that the company remains under CIRP, meaning shareholders face uncertainty around recovery and timeline of the resolution process.